Bulletin
Investor Alert

Semler Scientific Inc.

NAS: SMLR

GO

Set Alerts

Market Index

Overview Profile Charts Financials Historical Quotes Analyst Estimates Options SEC Filings Insiders
/marketstate/country/us
Semler Scientific Inc.

After Hours

 --Quotes are delayed by 20 min

Sep 29, 2023, 6:06 p.m.

SMLR
/zigman2/quotes/201267132/composite

$

25.37

Change

0.00 0.00%

Volume

Volume 860

Quotes are delayed by 20 min

/zigman2/quotes/201267132/composite

Previous close

$ 26.87

$ 25.37

Change

-1.50 -5.58%

Day low

Day high

$24.86

$26.96

Open

52 week low

52 week high

$19.12

$44.36

Open

Company Description

Semler Scientific, Inc. engages in the provision of technology and software solutions to improve the clinical effectiveness of healthcare providers. Its multi-test service platform, WellChec, comprehensively evaluates its customers’ patients for chronic disease, including heart attacks and strokes, ...

Semler Scientific, Inc. engages in the provision of technology and software solutions to improve the clinical effectiveness of healthcare providers. Its multi-test service platform, WellChec, comprehensively evaluates its customers’ patients for chronic disease, including heart attacks and strokes, using its QuantaFlo product as well as other tests. The company was founded by Herbert J. Semler, Guinasso Cindy and Shirley L. Semler on August 9, 2007 and is headquartered in Santa Clara, CA.

Valuation

P/E Current

15.33

P/E Ratio (with extraordinary items)

12.17

P/E Ratio (without extraordinary items)

18.43

Price to Sales Ratio

4.66

Price to Book Ratio

3.97

Price to Cash Flow Ratio

15.22

Enterprise Value to EBITDA

8.17

Enterprise Value to Sales

2.25

Total Debt to Enterprise Value

0.00

Efficiency

Revenue/Employee

446,346.00

Income Per Employee

112,795.00

Receivables Turnover

15.11

Total Asset Turnover

1.00

Liquidity

Current Ratio

7.13

Quick Ratio

7.06

Cash Ratio

6.28

Profitability

Gross Margin

92.50

Operating Margin

30.35

Pretax Margin

31.21

Net Margin

25.27

Return on Assets

25.27

Return on Equity

28.30

Return on Total Capital

33.80

Return on Invested Capital

28.19

Capital Structure

Total Debt to Total Equity

0.44

Total Debt to Total Capital

0.44

Total Debt to Total Assets

0.39

Long-Term Debt to Equity

0.29

Long-Term Debt to Total Capital

0.29

Officers and Executives

Name Age Officer Since Title
Dr. Douglas R. Murphy-Chutorian 67 2012 Chief Executive Officer & Director
Mr. Jim Kermode - 2015 Senior Vice President- Operations
Ms. Renae Cormier 50 2022 Head-Corporate Communications & Business Strategy

Insider Actions

– Purchase – Sale 1 – Number of Transactions
Date Name Shares Transaction Value
05/31/2023 Daniel S. Messina
Director 		909   Award at $0 per share. 0
02/01/2023 Wayne T. Pan
Director 		2,436   Award at $0 per share. 0
02/01/2023 Daniel S. Messina
Director 		3,045   Award at $0 per share. 0
02/01/2023 Arthur N. Leibowitz
Director 		2,436   Award at $0 per share. 0
02/01/2023 Cindy H. Moon
Director 		2,436   Award at $0 per share. 0
02/01/2023 Cindy H. Moon
Director 		1,071   Derivative/Non-derivative trans. at $41.05 per share. 43,964
11/04/2022 William H. C. Chang
119,754   Gift at $0 per share. 0
11/04/2022 William H. C. Chang
105,582   Gift at $0 per share. 0
11/04/2022 William H. C. Chang
105,582   Gift at $0 per share. 0
10/20/2022 Daniel S. Messina
Director 		649   Award at $0 per share. 0
09/30/2022 William H. C. Chang
238,248   Gift at $0 per share. 0
09/30/2022 William H. C. Chang
189,522   Gift at $0 per share. 0
09/30/2022 William H. C. Chang
189,522   Gift at $0 per share. 0
07/01/2022 Daniel S. Messina
Director 		871   Award at $0 per share. 0
04/01/2022 Daniel S. Messina
Director 		507   Award at $0 per share. 0
02/28/2022 Douglas R. Murphy-Chutorian
Chief Executive Officer; Director 		160   Disposition at $74.08 per share. 11,852
02/28/2022 Douglas R. Murphy-Chutorian
Chief Executive Officer; Director 		140   Disposition at $74.07 per share. 10,369
02/28/2022 Douglas R. Murphy-Chutorian
Chief Executive Officer; Director 		600   Disposition at $73.25 per share. 43,950
02/28/2022 Douglas R. Murphy-Chutorian
Chief Executive Officer; Director 		605   Disposition at $72.33 per share. 43,759
02/28/2022 Douglas R. Murphy-Chutorian
Chief Executive Officer; Director 		495   Disposition at $71.43 per share. 35,357
02/28/2022 Douglas R. Murphy-Chutorian
Chief Executive Officer; Director 		2,000   Derivative/Non-derivative trans. at $2.1 per share. 4,200
02/22/2022 Douglas R. Murphy-Chutorian
Chief Executive Officer; Director 		962   Disposition at $70.64 per share. 67,955
02/22/2022 Douglas R. Murphy-Chutorian
Chief Executive Officer; Director 		1,038   Disposition at $69.82 per share. 72,473
02/22/2022 Douglas R. Murphy-Chutorian
Chief Executive Officer; Director 		2,000   Derivative/Non-derivative trans. at $2.1 per share. 4,200
02/15/2022 Douglas R. Murphy-Chutorian
Chief Executive Officer; Director 		100   Disposition at $77.91 per share. 7,791
02/15/2022 Douglas R. Murphy-Chutorian
Chief Executive Officer; Director 		2   Disposition at $77.89 per share. 155
02/15/2022 Douglas R. Murphy-Chutorian
Chief Executive Officer; Director 		427   Disposition at $77.15 per share. 32,943
02/15/2022 Douglas R. Murphy-Chutorian
Chief Executive Officer; Director 		777   Disposition at $76.13 per share. 59,153
02/15/2022 Douglas R. Murphy-Chutorian
Chief Executive Officer; Director 		694   Disposition at $74.98 per share. 52,036
02/15/2022 Douglas R. Murphy-Chutorian
Chief Executive Officer; Director 		2,000   Derivative/Non-derivative trans. at $2.1 per share. 4,200
/news/latest/company/us/smlr

MarketWatch News on SMLR

  1. Semler Scientific downgraded to neutral from buy at B. Riley

    7:47 a.m. Nov. 2, 2022

    - Tomi Kilgore

  2. Semler Scientific stock price target cut to $70 from $145 at B. Riley

    8:48 a.m. March 7, 2022

    - Tomi Kilgore

  3. Semler Scientific stock price target raised to $121 from $100 at B. Riley

    9:43 a.m. Feb. 25, 2021

    - Tomi Kilgore

  4. Semler Scientific started at buy with $61 stock price target at B. Riley FBR

    7:45 a.m. June 23, 2020

    - Tomi Kilgore

/news/nonmarketwatch/company/us/smlr

Other News on SMLR

  1. 10-Q: SEMLER SCIENTIFIC, INC.

    4:17 p.m. May 12, 2023

    - Edgar Online - (EDG = 10Q, 10K)

  2. Top 5 4th Quarter Trades of Legato Capital Management LLC

    3:00 p.m. Feb. 1, 2023

    - GuruFocus.com

  3. 10-Q: SEMLER SCIENTIFIC, INC.

    4:15 p.m. Nov. 4, 2022

    - Edgar Online - (EDG = 10Q, 10K)

  8. Here's Why Investors Should Hold Exact Sciences (EXAS) Stock

    11:37 a.m. Sept. 28, 2022

    - Zacks.com

  12. Here's Why You Should Bet on ShockWave Medical (SWAV) Stock

    11:54 a.m. Sept. 22, 2022

    - Zacks.com

  13. McKesson (MCK) Stock Pares Gains Following Rx Savings Buyout

    12:25 p.m. Sept. 21, 2022

    - Zacks.com

At a Glance

Semler Scientific, Inc.

2340-2348 Walsh Avenue

Suite 2344

Santa Clara, California 95051

Phone

1 8777744211

Industry

Medical Equipment/Supplies

Sector

Health Care/Life Sciences

Fiscal Year-end

12/2023

View SEC Filings

Revenue

$56.69M

Net Income

$14.33M

2022 Sales Growth

6.9%

Employees

127.00

Annual Report for SMLR

/news/pressrelease/company/us/smlr

Press Releases on SMLR

  1. Semler Scientific Reports First Quarter 2023 Financial Results

    4:01 p.m. May 10, 2023

    - PR Newswire - PRF

  3. Semler Scientific Names Doug Murphy-Chutorian, M.D. as Interim CEO

    4:01 p.m. April 28, 2023

    - PR Newswire - PRF

  12. Semler Announces Investment in Monarch Medical Technologies

    9:05 a.m. Dec. 12, 2022

    - PR Newswire - PRF

Link to MarketWatch's Slice.